Investing $1,000 in These 2 Exceptional Growth Stocks Could Be a Brilliant Move
Teladoc Health (NYSE: TDOC) has provided several bumpy quarters for investors, many of whom have zeroed in on the company's series of multibillion-dollar impairment charges after apparently overpaying for Livongo back in 2020. Revenue rose 11% year over year in the first quarter to $629 million.